Just heard back from Tom in response to this proposed move, here’s what he said:
This sort of thing happens from time to time. The last time was in 2020 and the changes proposed were not codified.
It is currently going through a public comment period. It has elicited a very strong response from doctors and the societies that support them. We note the recent update from one of the private payers Cigna, that talks about coverage without any restrictions. The complete opposite to the MACs.
Seems like things like these are proposed fairly often, but don’t usually amount to anything. Interesting as well is the fact that one of the payers themselves (Cigna) have come out in support of procedures like canaloplasty (I believe it was posted about here when they did), so I can’t really see the proposed changes by the MACs amounting to anything. Just Glaukos doing whatever it can to stay alive I guess, they know how much better canaloplasty is than stents
- Forums
- ASX - By Stock
- Nova Eye Medical (EYE) Discussion
Just heard back from Tom in response to this proposed move,...
-
-
- There are more pages in this discussion • 2,274 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $44.66M |
Open | High | Low | Value | Volume |
20.0¢ | 20.0¢ | 19.5¢ | $9.907K | 50.65K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 65104 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 51773 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 65104 | 0.195 |
3 | 202141 | 0.190 |
1 | 20980 | 0.185 |
2 | 71691 | 0.180 |
5 | 114937 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 51773 | 2 |
0.205 | 44282 | 2 |
0.210 | 223212 | 2 |
0.215 | 304291 | 5 |
0.230 | 103718 | 2 |
Last trade - 13.43pm 13/09/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online